Relationship Between Cognitive Disorder and First-Line Targeted Therapy for Oncogene Driver–Positive Patients With Non–Small Cell Lung Cancer: Prospective Cohort Study
Cognitive disorder may lead to lower quality of life scores and shorter PFS in patients undergoing targeted therapy. Early screening and intervention for such patients could effectively improve clinical outcomes and quality of life.
Authors
- Maoxi Chen (ORCID: https://orcid.org/0000-0002-2164-4185)
- Ziran Bi (ORCID: https://orcid.org/0000-0002-9254-9660)
- Senbang Yao (ORCID: https://orcid.org/0000-0003-4769-4970)
- Wenjun Chen (ORCID: https://orcid.org/0009-0005-8367-2535)
- Huaidong Cheng (ORCID: https://orcid.org/0000-0001-6422-1257)
- Xueyang Hu (ORCID: https://orcid.org/0009-0009-3841-2477)
Institutions
- Anhui Medical University (CN)
- Anhui Provincial Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- JMIR Cancer
- Published
- 2025-09-18
- DOI
- https://doi.org/10.2196/59647
- Citations
- 1
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 1.52